Myriad Genetics' CEO Discusses Q1 2012 Results - Earnings Call Transcript
Myriad Genetics, Inc. (MYGN)
Q1 2012 Earnings Call
May 1, 2012 4:30 pm ET
Executives
Rebecca Chambers – Director of Investor RelationsPeter D. Meldrum – President and Chief Executive OfficerMark C. Capone – President, Myriad Genetic LaboratoriesJames S. Evans – Chief Financial Officer and TreasurerAnalystsScott Gleason – Stephens Inc.John Wood – Jefferies & Company, IncAmanda Murphy – William Blair & Company, L.L.C.Michael Yee – RBC Capital MarketsWilliam T. Cook – Piper Jaffray, Inc.Doug Schenkel – Cowen and Co.Tycho W. Peterson – JPMorgan Securities LLCDavid Ferreiro – Oppenheimer SecuritiesIsaac Ro – Goldman SachsKevin DeGeeter – Ladenburg Thalmann SecuritiesPresentationOperatorPrevious Statements by MYGN
» Myriad Genetics' CEO Discusses F2Q12 Results - Earnings Call Transcript
» Myriad Genetics' CEO Presents at 30th Annual J.P. Morgan Healthcare Conference (Transcript)
» Myriad Genetics' Management Presents at 22nd Annual Oppenheimer Healthcare Conference - Conference Call Transcript
» Myriad Genetics' CEO Discusses F1Q12 Results - Earnings Call Transcript
Good afternoon everyone, and welcome to the Myriad Genetics’ Third Fiscal Quarter Earnings Call. During the call, we will review the financial results we released today and the progress made this quarter on our strategic directives, after which we will host a question-and-answer session. If you have not had a chance to review the earnings release it can be found in the Investor Relations section of our website at myriad.com.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
